Remimazolam Inhibits Pyroptosis after Myocardial Ischemia-Reperfusion by Suppressing Nat10-Mediated Ac4C Acetylation of Nek7
International Heart Journal · 2025
DOI: 10.1536/ihj.24-668 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Heart Journal, 2025. Verfasst von Huafeng Feng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Fifth Affiliated Hospital of Southern Medical University, Guangzhou. Hauptthemen laut MEDLINE: Pyroptosis, Myocardial Reperfusion Injury, NIMA-Related Kinases, Acetyltransferases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The Fifth Affiliated Hospital of Southern Medical University, Guangzhou.
- Department of Anaesthesiology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Clinical Research Academy of Chinese Medicine, Guangzhou.
Zitieren
APA
Feng, H., Huang, W., Bi, X., & Tang, Z. (2025). Remimazolam Inhibits Pyroptosis after Myocardial Ischemia-Reperfusion by Suppressing Nat10-Mediated Ac4C Acetylation of Nek7. International Heart Journal. https://doi.org/10.1536/ihj.24-668
Vancouver
Feng H, Huang W, Bi X, Tang Z. Remimazolam Inhibits Pyroptosis after Myocardial Ischemia-Reperfusion by Suppressing Nat10-Mediated Ac4C Acetylation of Nek7. International Heart Journal. 2025. doi:10.1536/ihj.24-668
BibTeX
@article{Feng2025,
author = {Feng, Huafeng and Huang, Wei and Bi, Xinyu and Tang, Zhihang},
title = {Remimazolam Inhibits Pyroptosis after Myocardial Ischemia-Reperfusion by Suppressing Nat10-Mediated Ac4C Acetylation of Nek7},
journal = {International Heart Journal},
year = {2025},
doi = {10.1536/ihj.24-668}
}
EUVIMED